| Target Price | $47.94 |
| Price | $40.41 |
| Potential | 18.63% |
| Number of Estimates | 25 |
| 25 Analysts have issued a price target Amrize 2027 . The average Amrize target price is $47.94. This is 18.63% higher than the current stock price. The highest price target is $63.00 55.90% , the lowest is $32.32 20.02% . | |
| A rating was issued by 30 analysts: 17 Analysts recommend Amrize to buy, 11 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Amrize stock has an average upside potential 2027 of 18.63% . Most analysts recommend the Amrize stock at Purchase. |
27 Analysts have issued a sales forecast Amrize 2026 . The average Amrize sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
25 Analysts have issued an Amrize EBITDA forecast 2026. The average Amrize EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
26 Amrize Analysts have issued a net profit forecast 2026. The average Amrize net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Hold
➜
Underperform
|
Downgrade | Nov 16 2026 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Nov 16 2026 |
| Oppenheimer |
Outperform
➜
Outperform
|
Unchanged | Nov 02 2026 |
| DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Oct 30 2026 |
| Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 30 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 19 2026 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Oct 13 2026 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
Jefferies:
Hold
➜
Underperform
|
Nov 16 2026 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Nov 16 2026 |
|
Unchanged
Oppenheimer:
Outperform
➜
Outperform
|
Nov 02 2026 |
|
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Oct 30 2026 |
|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Oct 30 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 19 2026 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Oct 13 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


